Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Value of Abciximab in Patients With AMI Undergoing Primary PCI After Clopidogrel Pretreatment (BRAVE 3)

This study has been completed.
Technische Universität München
Information provided by:
Deutsches Herzzentrum Muenchen Identifier:
First received: August 20, 2005
Last updated: March 15, 2010
Last verified: March 2010